Daunorubicin [clinicaltrials_resource:c856a2c5c60836c7c00df3ba04344af1]
Zosuquidar in Combination With Daunorubicin and Cytarabine in Patients Ages 55-75 With Newly Diagnosed Acute Myeloid Leukemia (AML) [clinicaltrials:NCT00129168]Trial for Treatment of Adult Patients With Standard Risk Acute Lymphoblastic Leukemia With Chemotherapy and Rituximab [clinicaltrials:NCT00199004]German Multicenter Trial for the Treatment of Newly Diagnosed T-lymphoblastic Lymphoma in Adults [clinicaltrials:NCT00199017]German Multicenter Trial for Treatment of Newly Diagnosed Acute Lymphoblastic Leukemia in Adults (06/99) [clinicaltrials:NCT00199056]PETHEMA LAL-RI/96: Treatment for Patients With Standard Risk Acute Lymphoblastic Leukemia [clinicaltrials:NCT00494897]
intervention [clinicaltrials_vocabulary:intervention]
Daunorubicin [clinicaltrials_resource:c856a2c5c60836c7c00df3ba04344af1]
Bio2RDF identifier
c856a2c5c60836c7c00df3ba04344af1
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:c856a2c5c60836c7c00df3ba04344af1
intervention name [clinicaltrials_vocabulary:intervention-name]
Daunorubicin
identifier
clinicaltrials_resource:c856a2c5c60836c7c00df3ba04344af1
title
Daunorubicin
@en
type
label
Daunorubicin [clinicaltrials_resource:c856a2c5c60836c7c00df3ba04344af1]
@en